Considering the biological effects of GREM1 and BMP signaling, we speculated that the elevated GREM1 expression drove CRC development via reducing the activity of BMP receptors and inhibiting downstream TGF-β signaling. This evidence concerns the gene GREM1 and colorectal carcinoma.